Combinations of Single Chain Variable Fragments From HIV Broadly Neutralizing Antibodies Demonstrate High Potency and Breadth

Broadly neutralizing antibodies (bNAbs) are currently being assessed in clinical trials for their ability to prevent HIV infection. Single chain variable fragments (scFv) of bNAbs have advantages over full antibodies as their smaller size permits improved diffusion into mucosal tissues and facilitat...

Descripción completa

Detalles Bibliográficos
Autores principales: van Dorsten, Rebecca T., Wagh, Kshitij, Moore, Penny L., Morris, Lynn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481832/
https://www.ncbi.nlm.nih.gov/pubmed/34603312
http://dx.doi.org/10.3389/fimmu.2021.734110

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481832/
https://www.ncbi.nlm.nih.gov/pubmed/34603312
http://dx.doi.org/10.3389/fimmu.2021.734110

Ejemplares similares